Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms

Amm, J. E., Patel, N., Freeman, A., & Ching, J. B. A. (2013). Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide. Clinical Medicine Insights: Oncology, (), 235-245. https://doi.org/10.4137/CMO.S11670
Boudadi, K., & Antonarakis, E. S. (2016). Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer. Clinical Medicine Insights: Oncology, (), 1-9. https://doi.org/10.4137/CMO.S34534
Todenhofer, T., Stenzl, A., Hofbauer, L. C., & Rachner, T. D. (2015). Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies. International Journal of Endocrinology, 2015(), 145-153-217. https://doi.org/10.1155/2015/838202
Amm, J. E., & Ching, J. B. A. (2016). Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer. Clinical Medicine Insights: Oncology, (), 11-19. https://doi.org/10.4137/CMO.S30751
Yang, W. T. (2017). Identification of Critical Protein Targets Involved in Prostate Cancer Metastatic Progression [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201702298